Keyphrases
Oxytocin
100%
Schizophrenic Patients
100%
Vasopressin
100%
Arginine Vasopressin
100%
Emotional Perception
100%
Sex Effect
100%
Intranasal
100%
Emotional Recognition
100%
Social Cognition
45%
Facial Expression
27%
Face Emotion
27%
Social Behavior
18%
Emotion Identification
18%
Identity Testing
18%
Emotional State
9%
Nonapeptides
9%
Placebo
9%
Placebo-controlled
9%
Schizophrenia Symptoms
9%
Schizophrenia
9%
Patients with Schizophrenia
9%
Sex-specific Differences
9%
Emotion Recognition
9%
Angry Faces
9%
Treatment Conditions
9%
Eyes Test
9%
Discrimination Test
9%
Oxytocin Administration
9%
Schizoaffective Disorder
9%
Sex-specific
9%
Facial Emotion Recognition
9%
Hormone Administration
9%
Test Tasks
9%
Sad Faces
9%
Reading the Mind in the Eyes
9%
Emotion Discrimination
9%
Fearful Faces
9%
Neuroscience
Oxytocin
100%
Dementia Praecox
100%
Vasopressin
100%
Argipressin
100%
Face
54%
Social Cognition
36%
Vasotocin
36%
Placebo
18%
Behavior (Neuroscience)
9%
Nonapeptide
9%
Social Behavior
9%
Schizoaffective Disorder
9%
Crossover Study
9%
Nursing and Health Professions
Argipressin
100%
Vasopressin
100%
Oxytocin
100%
Argiprestocin
36%
Placebo
18%
Schizoaffective Psychosis
9%
Single Drug Dose
9%
Nonapeptide
9%
Pharmacology, Toxicology and Pharmaceutical Science
Oxytocin
100%
Vasopressin
100%
Argipressin
100%
Argiprestocin
36%
Placebo
18%
Nonapeptide
9%
Schizoaffective Psychosis
9%
Psychology
Schizophrenia
100%
Oxytocin
100%
Social Cognition
66%
Discrimination
16%
Schizoaffective Disorder
16%
Mind-Reading
16%